A-PBITMO
Chemical compound
From Wikipedia, the free encyclopedia
A-PBITMO is a synthetic cannabinoid receptor agonist that has been sold as a designer drug, first reported in Germany in July 2023,[1] and also subsequently identified in Russia.[2] It has an unusual 1,3-dihydrobenzimidazole-2-thione core structure which has not previously been seen in cannabinoid designer drugs.
| Identifiers | |
|---|---|
| |
| CAS Number |
|
| Chemical and physical data | |
| Formula | C23H30N2OS |
| Molar mass | 382.57 g·mol−1 |
| 3D model (JSmol) | |
| |
| |